There is another report indicates that METTL3-mediated M6A modification involves in the prognosis and IR-induced alteration of cell cycle progressing of pancreatic cancer cells by targeting PLK1 mRNA 3’UTR [53]. The gene discussed is METTL3; the disease is pancreatic neoplasm.